Updated: Editas abruptly terminates CMO Lisa Michaels, revealing little in terse SEC filing
In a surprise move, Editas Medicine parted with its top physician late Monday afternoon, noting in an SEC filing that CMO Lisa Michaels was “terminated, effective immediately.”
The biotech did not give a reason for the decision. Monday’s SEC filing only outlined her severance package, and Editas did not put out a corresponding press release. Company spokesperson Cristi Barnett wrote to Endpoints News in an email that the company will begin an external search, but provided no timeline.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters